131828-27-8

Basic information

• Product Name: 5-amino-2-(benzyloxy)-6-(hydroxymethyl)-3-isobutylpyrazine 4-oxide
• Synonyms: 5-amino-2-(benzyloxy)-6-(hydroxymethyl)-3-isobutylpyrazine 4-oxide
• CAS NO: 131828-27-8
• Molecular Weight: 303.361
• Mol File: 131828-27-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 5-amino-2-(benzyloxy)-6-(hydroxymethyl)-3-isobutylpyrazine 4-oxide(CAS DataBase Reference)
• NIST Chemistry Reference: 5-amino-2-(benzyloxy)-6-(hydroxymethyl)-3-isobutylpyrazine 4-oxide(131828-27-8)
• EPA Substance Registry System: 5-amino-2-(benzyloxy)-6-(hydroxymethyl)-3-isobutylpyrazine 4-oxide(131828-27-8)

Safety Data

• Hazardous Substances Data: 131828-27-8(Hazardous Substances Data)

Upstream product

• 76617-78-2 2-(hydroxyimino)-4-methylpentanoic acid 
• 131828-25-6 5-amino-6-(ethoxycarbonyl)-3-isobutyl-2(1H)-pyrazinone 4-oxide 
• 131828-24-5 N--2-(hydroxyimino)-4-methylpentanamide 
• 4502-00-5 sodium 4-methyl-2-oxovalerate 
• 100-39-0 benzyl bromide 
• 131828-26-7 5-amino-2-(benzyloxy)-6-(ethoxycarbonyl)-3-isobutylpyrazine 4-oxide 

Downstream Products

• 131827-66-2 2-(benzyloxy)-5-chloro-6-(hydroxymethyl)-3-isobutylpyrazine 4-oxide 
• 131828-29-0 2,5-bis-(benzyloxy)-3-isobutyl-6-<(tetrahydropyran-2-yloxy)methyl>pyrazine 4-oxide 
• 131828-30-3 2-(benzyloxy)-3-isobutyl-5-methoxy-6-<(tetrahydropyran-2-yloxy)methyl>pyrazine 4-oxide 
• 135074-03-2 1-(6-Benzyloxy-5-isobutyl-3-methoxy-4-oxy-pyrazin-2-ylmethyl)-1H-indole 
• 131828-28-9 2-(benzyloxy)-5-chloro-3-isobutyl-6-<(tetrahydropyran-2-yloxy)methyl>pyrazine 4-oxide 
• 131828-32-5 2-(benzyloxy)-3-isobutyl-6-<(methanesulfonyloxy)methyl>-5-methoxypyrazine 4-oxide 
• 131828-33-6 2-(benzyloxy)-6-(iodomethyl)-3-isobutyl-5-methoxypyrazine 4-oxide 
• 131828-31-4 2-(benzyloxy)-6-(hydroxymethyl)-3-isobutyl-5-methoxypyrazine 4-oxide 
• 135074-01-0 (6-Benzyloxy-5-isobutyl-4-oxy-pyrazin-2-yl)-methanol 

Relevant articles and documents

Indole derivatives

The novel indole derivatives and salts thereof represented by the general formula (1) STR1 possess, for example, an inhibitory effect against superoxide (O2-) released from the macrophage cells of guinea pig by stimulation and an anti-albuminuria activity against Masugi nephritis, and are useful in various clinical fields as an agent for preventing and treating diseases and cases associated with the above superoxide radical, for example, autoimmune diseases (e.g. rheumatism), arteriosclerosis, ischemic disease, ischemic encephalopathia, hepatic insufficiency and renal insufficiency, and also as an agent for preventing and treating nephritis.